Is Vertex Stock Still a Good Buy?
Over the past ten years or so, Vertex Pharmaceuticals (NASDAQ:…
Sell
32
LESL Quote, Financials, Valuation and Earnings
Last price:
$0.59
Seasonality move
:
-29.74%
Day range:
$0.61 - $0.65
52-week range:
$0.51 - $6.02
Dividend yield:
0%
P/E ratio:
151.00x
P/S ratio:
0.09x
P/B ratio:
--
Volume:
2.2M
Avg. volume:
3.9M
1-year change:
-84.73%
Market cap:
$117.1M
Revenue:
$1.3B
EPS (TTM):
-$0.15
Analysts' Opinion
-
Consensus RatingLeslies has received a consensus rating of Hold. The company's average rating is a Hold based on 1 Buy rating, 9 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $2.12, Leslies has an estimated upside of 235.79% from its current price of $0.63.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $0.55 representing 100% downside risk from its current price of $0.63.
Fair Value
-
According to the consensus of 10 analysts, Leslies has 235.79% upside to fair value with a price target of $2.12 per share.
LESL vs. S&P 500
-
Over the past 5 trading days, Leslies has overperformed the S&P 500 by 1.34% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Leslies does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Leslies has grown year-over-year revenues for 1 quarter straight. In the most recent quarter Leslies reported revenues of $175.2M.
Earnings Growth
-
Leslies earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Leslies reported earnings per share of -$0.24.
Enterprise value:
896.1M
EV / Invested capital:
--
Price / LTM sales:
0.09x
EV / EBIT:
16.63x
EV / Revenue:
0.67x
PEG ratio (5yr expected):
--
EV / Free cash flow:
27.09x
Price / Operating cash flow:
3.53x
Enterprise value / EBITDA:
10.31x
Gross Profit (TTM):
$474.1M
Return On Assets:
-2.72%
Net Income Margin (TTM):
-2.13%
Return On Equity:
--
Return On Invested Capital:
-4.67%
Operating Margin:
-22.66%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Income Statement | ||||||
| Revenue | $1.6B | $1.4B | $1.3B | $174M | $175.2M | |
| Gross Profit | $671.7M | $533.3M | $474.1M | $50.4M | $47.7M | |
| Operating Income | $224.2M | $92.7M | $53.9M | -$36.5M | -$39.7M | |
| EBITDA | $254.3M | $126.7M | $86.9M | -$28.1M | -$31.5M | |
| Diluted EPS | $0.78 | $0.10 | -$0.15 | -$0.21 | -$0.24 | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $355.6M | $375.5M | $508.5M | $392M | $341.6M | |
| Total Assets | $747.1M | $811.3M | $1.1B | $998.5M | $967M | |
| Current Liabilities | $192.9M | $254.2M | $254.6M | $204.6M | $194M | |
| Total Liabilities | $1.1B | $1.2B | $1.3B | $1.2B | $1.2B | |
| Total Equity | -$386.4M | -$381.3M | -$225.6M | -$198.6M | -$220M | |
| Total Debt | $803.7M | $792.6M | $877.2M | $817.8M | $790.6M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $7.8M | $119M | $74.3M | -$71.9M | -$105.1M | |
| Cash From Investing | -$142.2M | -$49.5M | -$41.1M | -$10.7M | -$4.6M | |
| Cash From Financing | $83.8M | -$63.8M | -$29.9M | $35.5M | $12.8M | |
| Free Cash Flow | -$24.2M | $75.4M | $33.1M | -$82.6M | -$109.8M | |
LESL
Sector
Market Cap
$117.1M
$401M
Price % of 52-Week High
10.5%
66.47%
Dividend Yield
0%
0%
Shareholder Yield
--
3.88%
1-Year Price Total Return
-84.73%
-17.67%
Beta (5-Year)
--
0.832
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$0.61
200-day SMA
Sell
Level
$2.24
Bollinger Bands (100)
Sell
Level
0.82 - 2.24
Chaikin Money Flow
Sell
Level
-127.4M
20-day SMA
Buy
Level
$0.61
Relative Strength Index (RSI14)
Sell
Level
41.58
ADX Line
Sell
Level
30.16
Williams %R
Neutral
Level
-26.2676
50-day SMA
Sell
Level
$0.86
MACD (12, 26)
Sell
Level
-0.08
25-day Aroon Oscillator
Sell
Level
-56
On Balance Volume
Sell
Level
-374.1M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (1.5533)
Sell
CA Score
(Annual)
Level (-2.7578)
Buy
Beneish M-Score
(Annual)
Level (-2.3327)
Sell
Momentum Score
Level (1)
Sell
Ohlson Score
Level (3.3785)
Buy
Piotroski F Score
(Annual)
Level (4)
Buy
Quality Ratio Score
Level (6)
Sell
Fundamental Score
Level (4)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Leslies Inc is a direct-to-consumer pool and spa care brand offering a comprehensive assortment of products across chemicals, equipment and parts, cleaning and maintenance equipment, and safety, recreational, and fitness-related products. The company offers its products and services for Residential Pool, Residential Spa, Professional Pool, and Commercial Pool consumers. Geographically, it operates only in the United States.
Stock Forecast FAQ
In the current month, LESL has received 1 Buy ratings 9 Hold ratings, and 0 Sell ratings. The LESL average analyst price target in the past 3 months is $2.12.
-
Where Will Leslies Stock Be In 1 Year?
According to analysts, the consensus estimate is that Leslies share price will rise to $2.12 per share over the next 12 months.
-
What Do Analysts Say About Leslies?
Analysts are divided on their view about Leslies share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Leslies is a Sell and believe this share price will drop from its current level to $0.55.
-
What Is Leslies's Price Target?
The price target for Leslies over the next 1-year time period is forecast to be $2.12 according to 10 Wall Street analysts, 1 of them rates the stock a Buy, 0 rate the stock a Sell, and 9 analysts rate the stock a Hold.
-
Is LESL A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Leslies is a Hold. 9 of 10 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of LESL?
You can purchase shares of Leslies via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Leslies shares.
-
What Is The Leslies Share Price Today?
Leslies was last trading at $0.59 per share. This represents the most recent stock quote for Leslies. Yesterday, Leslies closed at $0.63 per share.
-
How To Buy Leslies Stock Online?
In order to purchase Leslies stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Okta Stock Finally Gaining Investor Confidence?
Given how digital transformation has proliferated, cyberattacks have also been…
Is The Trade Desk the Best Advertising Stock Now?
The worldly backdrop is now shrouded in heavy uncertainty and…
Stock Ideas
Buy
59
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Buy
58
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Buy
55
Is NVDA Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 37x
Alerts
Buy
85
HIMS alert for Apr 30
Hims & Hers Health [HIMS] is down 6.65% over the past day.
Buy
54
EAT alert for Apr 30
Brinker International [EAT] is down 2.41% over the past day.
Sell
16
NSP alert for Apr 30
Insperity [NSP] is down 5.73% over the past day.
